FGF14 IS A FUNCTIONAL TUMOR SUPPRESSOR THROUGH INHIBITING PI3K/AKT/MTOR PATHWAY IN COLORECTAL CANCER

被引:1
|
作者
Su, Tianhong [1 ]
Zhang, Ning [1 ]
Huang, Linlin [1 ]
Wei, Guangyan [1 ]
Peng, Sui [1 ]
Zeng, Zhirong [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
关键词
D O I
10.1136/gutjnl-2019-IDDFabstracts.28
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IDDF2019-A
引用
收藏
页码:A15 / A15
页数:1
相关论文
共 50 条
  • [21] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [22] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [23] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [24] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    [J]. MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [25] Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway
    Bai, Xue
    Ma, Yaxin
    Zhang, Guobin
    [J]. ONCOLOGY REPORTS, 2015, 33 (06) : 3085 - 3092
  • [26] TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling
    Dai, Youyi
    Duan, Huaxin
    Duan, Chaojun
    Zhu, Hong
    Zhou, Rongrong
    Pei, Haiping
    Shen, Liangfang
    [J]. ONCOTARGETS AND THERAPY, 2017, 10 : 1603 - 1611
  • [27] NICOTINE INDUCES TUMOR AGGRESSIVENESS AND CHEMORESISTANCE THROUGH ACTIVATION OF PI3K/AKT/MTOR PATHWAY IN BLADDER CANCER
    Yuge, Kazuyuki
    Kikuchi, Eiji
    Hagiwara, Masayuki
    Yasumizu, Yota
    Kosaka, Takeo
    Miyajima, Akira
    Oya, Mototsugu
    [J]. JOURNAL OF UROLOGY, 2014, 191 (04): : E362 - E362
  • [28] Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer
    Yuge, Kazuyuki
    Kikuchi, Eiji
    Hagiwara, Masayuki
    Yasumizu, Yota
    Tanaka, Nobuyuki
    Kosaka, Takeo
    Miyajima, Akira
    Oya, Mototsugu
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (09) : 2112 - 2120
  • [29] Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer
    Johnson, Sara M.
    Gulhati, Pat
    Rampy, Bill A.
    Han, Yimei
    Rychahou, Piotr G.
    Doan, Hung Q.
    Weiss, Heidi L.
    Evers, B. Mark
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 767 - 776
  • [30] HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway
    Wang, Haowei
    Chen, Yujia
    Yuan, Qinzi
    Chen, Lixia
    Dai, Peiling
    Li, Xuenong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12